CAPTRUST Financial Advisors
RLAY icon

CAPTRUST Financial Advisors’s Relay Therapeutics RLAY Stock Holding History

CAPTRUST Financial Advisors’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$723K Buy
38,632
+1,863
+5% +$27K ﹤0.01% 1932
2026
Q1 		$366K Buy
36,769
+1,203
+3% +$10.8K ﹤0.01% 2250
2025
Q4 		$301K Buy
35,566
+10,338
+41% +$73.8K ﹤0.01% 2248
2025
Q3 		$132K Buy
25,228
+11,117
+79% +$42.4K ﹤0.01% 2486
2025
Q2 		$48.8K Buy
+14,111
New +$42K ﹤0.01% 2425
2022
Q3 		– Sell
-13
Closed – – 3631
2022
Q2 		$0 Buy
+13
New +$279 ﹤0.01% 5099
2022
Q1 		– Sell
-10
Closed – – 5099
2021
Q4 		$0 Buy
+10
New +$316 ﹤0.01% 4887
2021
Q3 		– Sell
-7
Closed – – 4739
2021
Q2 		$0 Buy
+7
New +$231 ﹤0.01% 4633

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

CAPTRUST Financial Advisors's RLAY Position: Q2 2026 in Review

CAPTRUST Financial Advisors increased its Relay Therapeutics (RLAY) stake by 5.1% in Q2 2026, buying an estimated $27K and bringing the position to 38,632 shares worth $723K. The position accounts for ﹤0.01% of the portfolio, ranked #1932.

CAPTRUST Financial Advisors first reported a position in RLAY in Q2 2021 and has held it in 8 quarters since. 258 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • CAPTRUST Financial Advisors held 38,632 shares of Relay Therapeutics worth $723K as of Q2 2026.
  • CAPTRUST Financial Advisors bought 1,863 Relay Therapeutics shares in Q2 2026, an estimated $27K.
  • Relay Therapeutics made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q2 2026, its #1932 holding.
  • CAPTRUST Financial Advisors first reported a position in Relay Therapeutics in Q2 2021 and has held it in 8 quarters since.
  • 258 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.